Nemonoxacin treatment of patients with diabetic foot infection: A pilot study

ConclusionIn this small DFI patient population, nemonoxacin produced excellent clinical and microbiological responses, was well tolerated, and effectively penetrated infected tissues. Once-daily oral nemonoxacin treatment appears effective in DFI patients.NCT registration numberNCT00685698.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research